Related Experiment Videos
Determining hypertensive end-organ damage in trials: a review of current methodologies and techniques
W H Birkenhäger1, P W de Leeuw
1Erasmus University, Rotterdam, The Netherlands.
Insights
Identifying hypertensive end-organ damage is vital for long-term hypertension trials. Accurate assessment of target organ damage, including brain, heart, and kidneys, requires combining clinical skills with diagnostic techniques.
Area of Science:
- Cardiology
- Nephrology
- Neurology
- Ophthalmology
Background:
- Long-term hypertension trials critically depend on assessing end-organ damage.
- Identifying vascular lesions and functional deterioration in target organs is essential for evaluating treatment efficacy and cardiovascular prognosis.
Purpose of the Study:
- To review the methods for determining hypertensive end-organ damage in clinical trials.
- To discuss the challenges and compromises in selecting diagnostic techniques for hypertension studies.
Main Methods:
- Review of diagnostic techniques for assessing target organ damage in hypertension.
- Analysis of factors influencing the choice of methods, including convenience, patient compliance, and cost.
Main Results:
- Hypertensive end-organ damage affects sensitive organs such as the brain, eyes, heart, conduit arteries, and kidneys.
- Diagnostic accuracy relies on integrating clinical judgment with ancillary investigative methods.
Conclusions:
- The selection of diagnostic tools for hypertension trials involves balancing technological capabilities with practical constraints.
- Effective management of hypertension requires careful consideration of end-organ damage assessment strategies.
Abstract:
The determination of hypertensive end-organ damage is the most crucial aspect of any long-term hypertension trial. Definition of inclusion criteria and withdrawal rules, and the evaluation of the treatment regimen in light of the cardiovascular prognosis, are all largely dependent on the trialists' abilities to identify vascular lesions and/or functional deteriorations of the major target organs. Although the vascular complications of hypertension tend to be diffuse, some organs and tissues are particularly sensitive: brain, eye fundus, heart, conduit arteries, and kidneys. To achieve a modicum of diagnostic accuracy, trial investigators will have to combine clinical acumen with a selection of ancillary techniques. This article reviews the compromises resulting from weighing the available technological potential against such conflicting factors as convenience and compliance of trial subjects, and expenditure.